Saturday 17 October 2026
Export AORT’s income statement to Excel — free account
Artivion, Inc.
AORT Healthcare Medical Devices
Artivion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $441.3 million, up 13.6% from fiscal 2024. In the quarter to June 2026, revenue grew 11.3%, EPS fell 1,033.3%, free cash flow fell 202.5% and total debt rose 67.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
21.78
0.09
−0.41%
Follow AORT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
217.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 583.84 | 0.00 | 173.64 | 57.58 |
Piotroski F-Score |
7 | 4 | 5 | 2 | 5 | 3 | 7 | 5 | 4 | 5 |
P/S ratio |
4.69 | 3.07 | 2.07 | 1.50 | 2.65 | 3.53 | 3.64 | 3.93 | 3.32 | 3.36 |
Altman Z-Score |
3.73 | 2.28 | 1.58 | 1.33 | 1.69 | 1.80 | 2.80 | 3.00 | 1.95 | 4.81 |
P/FCF ratio |
0.00 | 166.60 | 141.35 | 0.00 | 0.00 | 177.33 | 129.66 | 252.35 | 151.15 | 44.76 |
Altman Z″-Score (non-manufacturers) |
3.05 | 2.50 | 2.28 | 2.30 | 2.40 | 2.30 | 2.86 | 2.95 | 2.75 | 5.29 |
Beneish M-Score |
(2.38) | (2.54) | (2.76) | (2.38) | (2.40) | (2.79) | (2.50) | (2.53) | (1.91) | (2.93) |
P/Operating CF |
105.71 | 117.52 | 67.52 | (2,171.32) | 1,107.97 | 164.02 | 948.61 | 54.85 | 105.48 | 119.97 |
P/B ratio |
4.61 | 4.31 | 2.60 | 1.66 | 2.64 | 2.72 | 3.52 | 3.76 | 2.28 | 2.90 |
Price to Tangible BV |
54.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.45 |
EV/Sales |
5.03 | 3.75 | 2.78 | 2.37 | 3.52 | 4.46 | 4.32 | 4.62 | 4.30 | 3.43 |
EV/EBITDA |
39.51 | 23.07 | 34.12 | 25.96 | 32.77 | 48.76 | 33.72 | 44.29 | 46.04 | 20.51 |
EV/Operating CF |
55.68 | 65.44 | 52.23 | (144.30) | (406.88) | 91.27 | 75.34 | 122.86 | 75.49 | 31.42 |
EV/FCF |
(726.43) | 203.47 | 189.92 | (38.32) | (58.43) | 223.94 | 153.76 | 296.45 | 195.52 | 45.82 |
Quick Ratio |
1.66 | 2.09 | 2.30 | 2.19 | 2.52 | 1.83 | 1.99 | 2.71 | 2.15 | 2.90 |
Current Ratio |
3.53 | 4.34 | 4.85 | 4.98 | 5.51 | 3.88 | 4.15 | 5.19 | 4.18 | 4.89 |
Net Debt/EBITDA |
2.72 | 4.18 | 8.73 | 9.51 | 8.05 | 10.15 | 5.28 | 6.59 | 10.45 | 0.47 |
Debt/Assets |
24.62% | 40.20% | 39.17% | 40.87% | 39.53% | 37.62% | 36.51% | 39.02% | 38.29% | 22.64% |
Debt/Equity |
0.49 | 1.15 | 1.10 | 1.10 | 1.04 | 0.90 | 0.77 | 0.81 | 0.82 | 0.34 |
Asset Turnover |
0.53 | 0.49 | 0.46 | 0.40 | 0.38 | 0.36 | 0.47 | 0.45 | 0.42 | 0.73 |
Operating CF/Net income |
4.09 | (1.67) | (0.62) | 0.27 | 0.18 | (0.75) | 9.27 | (3.51) | 2.97 | 1.87 |
Capex/Depreciation |
(1.74) | (0.46) | (0.42) | (0.55) | (0.59) | (0.41) | (0.44) | (0.32) | (0.68) | (0.74) |
Interest Coverage |
1.27 | 1.13 | 0.23 | 0.34 | 0.48 | 0.15 | 1.14 | 0.59 | 1.63 | 7.17 |
| 2.69% | (4.78%) | (10.80%) | (6.53%) | (4.68%) | (5.39%) | 0.61% | (1.02%) | 1.50% | 5.80% | |
| 1.17% | (1.69%) | (3.93%) | (2.45%) | (1.86%) | (2.38%) | 0.29% | (0.48%) | 0.80% | 4.25% | |
ROIC |
3.51% | 4.50% | 0.67% | 0.70% | 0.91% | 0.27% | 2.25% | 1.28% | 1.08% | 6.11% |
Return on Tangible Assets |
3.03% | (5.14%) | (11.70%) | (8.08%) | (6.13%) | (8.00%) | 0.98% | (1.60%) | 2.14% | 7.79% |
Average Days of Receivables |
85.75 | 80.69 | 76.44 | 80.94 | 70.97 | 70.27 | 73.81 | 71.42 | 98.98 | 60.90 |
Research and Development Expense of Revenue |
7.02% | 7.32% | 8.11% | 12.39% | 11.89% | 9.56% | 8.31% | 8.79% | 10.26% | 7.45% |
Selling, General and Administrative Expense of Revenue |
51.32% | 46.70% | 59.03% | 50.17% | 56.81% | 55.73% | 51.77% | 53.48% | 53.35% | 50.75% |
Intangible Assets out of Total Assets |
0.46 | 0.50 | 0.53 | 0.56 | 0.57 | 0.62 | 0.57 | 0.61 | 0.62 | 0.46 |
Share Based Compensation of Revenue |
5.53% | 3.67% | 4.07% | 3.93% | 3.58% | 2.73% | 3.19% | 2.41% | 3.65% | 3.51% |
Graham Net Nets |
(0.04) | (0.19) | (0.31) | (0.49) | (0.31) | (0.25) | (0.13) | (0.11) | (0.21) | 0.07 |
Graham Number |
6.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.83 | 0.00 | 4.56 | 6.98 |
Earnings Yield |
0.46% | (1.08%) | (4.18%) | (4.08%) | (1.87%) | (1.91%) | 0.17% | (0.29%) | 0.58% | 1.74% |
Free Cash Flow Yield |
(0.15%) | 0.60% | 0.71% | (4.12%) | (2.27%) | 0.56% | 0.77% | 0.40% | 0.66% | 2.23% |
Revenue per Share |
9.73 | 9.32 | 8.69 | 7.84 | 7.67 | 6.69 | 7.44 | 7.22 | 5.75 | 5.66 |
Operating CF per Share |
0.88 | 0.53 | 0.46 | (0.13) | (0.07) | 0.33 | 0.43 | 0.27 | 0.33 | 0.62 |
Capex per Share |
(0.86) | (0.27) | (0.24) | (0.31) | (0.36) | (0.22) | (0.22) | (0.16) | (0.20) | (0.19) |
Free Cash Flow per Share |
0.02 | 0.27 | 0.22 | (0.44) | (0.43) | 0.10 | 0.21 | 0.11 | 0.13 | 0.42 |
Cash per Share |
1.43 | 1.28 | 1.45 | 0.98 | 1.41 | 1.64 | 0.92 | 1.16 | 1.23 | 1.80 |
Shareholders Equity per Share |
9.89 | 6.63 | 6.92 | 7.10 | 7.71 | 8.68 | 7.70 | 7.55 | 8.39 | 6.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.89 | 6.63 | 6.92 | 7.10 | 7.71 | 8.68 | 7.70 | 7.55 | 8.39 | 6.56 |
Free Cash Flow |
0.84 | 11.05 | 9.07 | (17.57) | (16.65) | 3.88 | 7.76 | 4.10 | 4.17 | 13.52 |
Working Capital |
256.53 | 223.26 | 222.81 | 197.66 | 202.74 | 174.12 | 142.20 | 144.65 | 136.34 | 117.13 |
Capital Expenditures |
(39.04) | (11.19) | (9.75) | (12.41) | (14.06) | (8.48) | (8.07) | (5.79) | (6.63) | (6.20) |
Net Current Asset Value |
(78.48) | (222.82) | (229.95) | (231.13) | (244.63) | (226.10) | (132.57) | (116.86) | (133.35) | 40.08 |
EV/EBIT |
65.81 | 37.43 | 171.23 | 119.91 | 129.58 | 462.48 | 69.97 | 130.36 | 102.32 | 28.39 |
Capex to Sales |
0.09 | 0.03 | 0.03 | 0.04 | 0.05 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 |
Price to Operating Income |
61.28 | 30.65 | 127.44 | 75.98 | 97.73 | 366.20 | 59.00 | 110.97 | 79.10 | 27.74 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.35 | 0.66 | 0.60 | 0.58 | 0.64 | 0.63 | 0.57 | 0.58 | 0.29 | 0.45 |
Cash ROIC |
0.11% | 1.71% | 1.39% | (2.76%) | (2.49%) | 0.56% | 1.43% | 0.76% | 0.77% | 4.00% |
Accounts Receivable Turnover |
4.66 | 4.86 | 4.93 | 4.91 | 5.59 | 4.84 | 5.15 | 5.11 | 4.65 | 6.36 |
Accounts Payable Turnover |
9.24 | 8.93 | 9.86 | 9.93 | 10.12 | 8.80 | 10.75 | 10.38 | 7.87 | 11.90 |
Inventory Turnover |
1.82 | 1.73 | 1.60 | 1.47 | 1.35 | 1.36 | 1.89 | 1.95 | 1.67 | 3.00 |
Average Days of Payables |
37.27 | 46.93 | 38.94 | 39.38 | 37.45 | 41.11 | 38.36 | 30.66 | 58.38 | 34.10 |
Days of Inventory on Hand |
214.74 | 208.32 | 239.70 | 244.32 | 277.28 | 312.01 | 207.82 | 184.73 | 279.06 | 156.10 |
Average Receivables |
94.79 | 80.02 | 71.86 | 63.84 | 53.43 | 52.31 | 53.65 | 51.44 | 40.77 | 28.38 |
Average Payables |
17.01 | 15.64 | 12.66 | 11.20 | 10.01 | 9.71 | 8.67 | 8.66 | 7.76 | 5.17 |
Average Inventory |
86.10 | 80.87 | 78.23 | 75.72 | 75.00 | 63.05 | 49.27 | 46.08 | 36.49 | 20.47 |
Average Assets |
836.95 | 790.75 | 777.60 | 777.93 | 791.23 | 697.53 | 588.37 | 580.39 | 452.92 | 248.66 |
Average Common Equity |
362.22 | 278.99 | 283.05 | 292.53 | 314.72 | 307.20 | 280.38 | 276.06 | 243.02 | 182.12 |
Columns are period end dates